Cell-Based Therapies for Parkinson's Disease
Summary
Parkinson’s disease is characterised by progressive loss of midbrain dopaminergic neurons, leading to motor impairment and reduced quality of life. Cell-based therapies aim to replace or restore these neurons using transplantable cells derived from human foetal tissue or pluripotent stem cells. Advances in differentiation protocols have enabled the generation of ventral midbrain dopamine neuron progenitors under defined conditions, addressing ethical and supply limitations associated with foetal tissue. Key challenges include ensuring long-term survival, integration and functional connectivity of transplanted cells, while minimising risks such as immune rejection, graft-induced dyskinesias and tumour formation. Clinical translation requires standardised manufacturing, robust safety testing and strategies to modulate host immune responses for sustained benefit.
Research from Nature Portfolio
Preclinical evaluation of clinical-grade human iPSC-derived dopaminergic progenitors has demonstrated safety and efficacy in rodent models of Parkinson’s disease. The studied cells exhibited no tumourigenicity, lacked undifferentiated contaminants and, when transplanted into lesioned rats, survived to reinnervate the striatum and restore motor function, underpinning the initiation of human clinical trials. Single-cell transcriptomic analysis of grafts in rat models has revealed unexpected cellular diversity within human embryonic stem cell- and foetal-derived grafts, including perivascular-like cells alongside neurons and astrocytes. This work provides crucial insight into graft composition, informing strategies to enrich therapeutic cell types and improve functional integration.
Cell-Based Therapies for Parkinson's Disease publication trend
The graph below shows the total number of articles in cell-based therapies for parkinson's disease across all publications each year (not limited to Nature Index journals).
Technical terms
Human pluripotent stem cell (hPSC): A cell capable of self-renewal and differentiation into all body cell types, including dopamine neurons.
Induced pluripotent stem cell (iPSC): A pluripotent cell generated from adult somatic cells by reprogramming, retaining the donor’s genetic background.
Dopaminergic neuron: A nerve cell that synthesises and releases dopamine, critical for motor control and depleted in Parkinson’s disease.
Engraftment: The process by which transplanted cells survive, integrate and function within host tissue.
Immunogenicity: The potential of transplanted cells to provoke an immune response, influencing graft survival.
Single-cell transcriptomics: A technique for profiling gene expression in individual cells, revealing cellular composition and diversity.
References
- Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease. Nature Communications (2020).
- Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson’s disease. Nature Communications (2020).
- TNF-NF-κB-p53 axis restricts i n vivo survival of hPSC-derived dopamine neurons. Cell (2024).
- Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses. Cell Research (2024).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.